Cambridge, MA, 1st September 2015
Aldatu was selected to participate in the Innovation Challenge as part of the Redefining Early State Investments (RESI) Conference being held in Boston on September 16th, 2015. Aldatu will join 29 other innovative life science companies in therapeutics, diagnostics, medical devices, and healthcare IT tracks in an exhibition-style presentation format throughout the day-long conference.
Aldatu Biosciences is an awardee of the National Institutes of Health (NIH), who is sponsoring Aldatu’s participation in the Innovation Challenge.
About the RESI conference – www.resiconference.com
The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that will be establishing a global circuit for early stage life sciences companies to source investors, create relationships, and eventually, get funding. The RESI conference focuses on the diverse breadth of early stage investors that LSN tracks, including Family Offices, Venture Philanthropy Funds, VCs, Angel Groups, Corporate Venture Capital Funds, and more. The RESI Partnering Forum allows fundraising executives to identify and book up to 16 meetings with life science investors who fit their company’s technology sector and stage of development. Additionally, through an expansive series of panels and workshops, attendees will have the chance to hear firsthand accounts from investors explaining their current investment mandates and process for identifying and qualifying candidates. RESI is sponsored in part by the Life Science Network (LSN) and Johnson & Johnson Innovations/JLABS.
ALDATU BIOSCIENCES 2021.